Final results of a rollover study assessing telaprevir in combination with peginterferon alfa-2a and ribavirin in chronic HCV patients with well-characterized null response, partial response, viral breakthrough, or relapse after prior PR treatment

Authors
Category Primary study
JournalGastroenterology
Year 2010
This article has no abstract
Epistemonikos ID: b982f26340b5051f2bce849ff2ab890019723620
First added on: Feb 04, 2025